When a large-scale vaccine trial needed to move fast, Velocity delivered — not once, but twice, across two continents.
In the United States, Velocity was the sole site network selected to enroll participants for the trial. Across just 10 sites, the team enrolled 1,000 participants in 3.5 weeks. That’s the kind of speed that only becomes possible when recruitment infrastructure, trained staff, and operational consistency work in concert across a fully integrated network.
The results in the United Kingdom were equally compelling. Velocity’s four UK sites enrolled one-fifth of the entire study — outperforming the average enrollment of all other sites in the trial by 21% (164 vs. 136 participants per site) and outpacing every other site network involved.
Together, these results illustrate what Velocity at Scale means in practice: not just the ability to run trials across multiple geographies, but the ability to outperform in each of them. For sponsors designing global vaccine programs, having a partner that can deliver consistently — and competitively — across the US and Europe isn’t a nice-to-have. It’s a differentiator.
